- Coronavirus News
- Student News
- Submit News
Dr. Yongbin Zhang of the U.S. Food and Drug Administration (FDA) will give a seminar at 3 p.m. Monday, Oct. 27, in Room 139 Shrenk Hall. The title of his presentation is “Characterizations in Nanotoxicity Assessment and Nanomedicine Development: A Regulatory Perspective.”
As a member of the FDA Nanotechnology Core Facility, Zhang established the first nanotoxicology laboratory to develop and conduct several nanotoxicology research projects starting in 2011. He has received many awards including a FDA Outstanding Junior Investigator Award in Nanotoxicology Research in 2012 and a FDA Outstanding Service Award in 2013. He has also served on editorial boards of various high-impact journals in toxicology and nanotechnology.